GAMCO Investors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04M Sell
748,743
-125,709
-14% -$752K 0.04% 402
2025
Q4
$6.08M Sell
874,452
-31,592
-3% -$208K 0.06% 320
2025
Q3
$5.84M Sell
906,044
-90,963
-9% -$622K 0.06% 321
2025
Q2
$6.64M Sell
997,007
-46,434
-4% -$239K 0.07% 299
2025
Q1
$6.75M Sell
1,043,441
-31,700
-3% -$228K 0.07% 277
2024
Q4
$8.67M Buy
1,075,141
+12,874
+1% +$106K 0.09% 246
2024
Q3
$8.67M Sell
1,062,267
-113,000
-10% -$745K 0.09% 253
2024
Q2
$8.19M Sell
1,175,267
-76,702
-6% -$580K 0.09% 249
2024
Q1
$13.3M Sell
1,251,969
-16,632
-1% -$145K 0.13% 190
2023
Q4
$10.2M Sell
1,268,601
-109,874
-8% -$800K 0.11% 218
2023
Q3
$11.3M Sell
1,378,475
-37,470
-3% -$323K 0.13% 197
2023
Q2
$11.3M Buy
1,415,945
+38,700
+3% +$285K 0.12% 204
2023
Q1
$11.2M Buy
1,377,245
+52,111
+4% +$418K 0.12% 205
2022
Q4
$8.32M Sell
1,325,134
-332,910
-20% -$2.33M 0.09% 244
2022
Q3
$11.4M Buy
1,658,044
+49,612
+3% +$345K 0.13% 197
2022
Q2
$13.4M Buy
1,608,432
+45,838
+3% +$641K 0.15% 181
2022
Q1
$35.7M Buy
1,562,594
+302,479
+24% +$7.39M 0.32% 90
2021
Q4
$34.8M Buy
1,260,115
+344,913
+38% +$9.23M 0.3% 93
2021
Q3
$25.5M Buy
915,202
+100,069
+12% +$2.84M 0.23% 128
2021
Q2
$23.9M Buy
815,133
+49,535
+6% +$1.5M 0.2% 141
2021
Q1
$24.3M Sell
765,598
-9,997
-1% -$293K 0.21% 134
2020
Q4
$16.1M Buy
775,595
+118,495
+18% +$2.21M 0.15% 185
2020
Q3
$10.2M Buy
657,100
+157,150
+31% +$2.71M 0.11% 218
2020
Q2
$9.14M Sell
499,950
-112,953
-18% -$1.99M 0.1% 224
2020
Q1
$9.5M Buy
612,903
+571,103
+1,366% +$13.8M 0.11% 214
2019
Q4
$1.25M Buy
41,800
+600
+1% +$15.6K 0.01% 583
2019
Q3
$900K Buy
41,200
+10,000
+32% +$229K 0.01% 620
2019
Q2
$787K Hold
31,200
0.01% 650
2019
Q1
$771K Buy
+31,200
New +$745K 0.01% 615
2018
Q1
Sell
-12,000
Closed -$249K 836
2017
Q4
$249K Buy
+12,000
New +$190K ﹤0.01% 776

Other funds holding BHC

GAMCO Investors's BHC Position: Q1 2026 in Review

GAMCO Investors reduced its Bausch Health (BHC) stake by 14% in Q1 2026, selling an estimated $752K and leaving 748,743 shares worth $4.04M. The position accounts for 0.04% of the portfolio, ranked #402.

GAMCO Investors first reported a position in BHC in Q4 2017 and has held it in 30 quarters since. The position peaked at $35.7M in Q1 2022. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • GAMCO Investors held 748,743 shares of Bausch Health worth $4.04M as of Q1 2026.
  • GAMCO Investors sold 125,709 Bausch Health shares in Q1 2026, an estimated $752K.
  • Bausch Health made up 0.04% of GAMCO Investors's portfolio in Q1 2026, its #402 holding.
  • GAMCO Investors first reported a position in Bausch Health in Q4 2017 and has held it in 30 quarters since.
  • GAMCO Investors's Bausch Health position peaked at $35.7M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.